Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

Title
Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
Authors
Keywords
-
Journal
LEUKEMIA RESEARCH
Volume 33, Issue 11, Pages 1481-1484
Publisher
Elsevier BV
Online
2009-02-05
DOI
10.1016/j.leukres.2008.12.020

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started